Eğitim Bilgileri
2006 - 2011
2006 - 2011Lisans
İnönü Üniversitesi, Eczacılık Fakültesi, Türkiye
Akademik Ünvanlar / Görevler
2014 - Devam Ediyor
2014 - Devam EdiyorAraştırma Görevlisi
Erzincan Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü
Makaleler
Tümü (9)
SCI-E, SSCI, AHCI (8)
SCI-E, SSCI, AHCI, ESCI (9)
ESCI (1)
Scopus (9)
TRDizin (1)
2025
20251. Optimizing riboflavin delivery with co-crystal and in situ hydrogel formulations for management of keratoconus: A comprehensive investigation with in vitro, ex vivo and in vivo studies
AYTEKİN E., Kaya M. Z., POLAT H. K., ÇAKMAK H. B., ÇELEBİER M., PALASKA E., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.674, 2025 (SCI-Expanded, Scopus)
2024
20242. Harnessing silk fibroin microparticles for metformin delivery: A novel approach to treating corneal neovascularization
Polat H. K., AYTEKİN E., KARAKUYU N. F., Çaylı Y., ÇALAMAK S., Demirci N., et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
, cilt.96, 2024 (SCI-Expanded, Scopus)
2024
20243. Formulation of hesperidin-loaded in situ gel for ocular drug delivery: a comprehensive study
GÖZCÜ S., Polat H. K., Gültekin Y., ÜNAL S., KARAKUYU N. F., Şafak E. K., et al.
Journal of the Science of Food and Agriculture
, 2024 (SCI-Expanded, Scopus)
2023
20234. Development and characterization of in situ gelling system containing atorvastatin-loaded polycaprolactone nanoparticles for periodontal diseases
ÜNAL S., Doğan O., Polat H. K., AKTAŞ Y.
Journal of Research in Pharmacy
, cilt.27, sa.5, ss.1951-1973, 2023 (ESCI, Scopus, TRDizin)
2023
20235. Formulation development of Lornoxicam loaded heat triggered ocular in-situ gel using factorial design
Polat H. K., ÜNAL S., AYTEKİN E., KARAKUYU N. F., PEZİK E., HAYDAR M. K., et al.
Drug Development and Industrial Pharmacy
, cilt.49, sa.9, ss.601-615, 2023 (SCI-Expanded, Scopus)
2022
20226. Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation
POLAT H. K., Kurt N., AYTEKİN E., AKDAĞ ÇAYLI Y., Pehlivan S., ÇALIŞ S.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
, cilt.38, sa.6, ss.412-423, 2022 (SCI-Expanded, Scopus)
2022
20227. Novel Drug Delivery Systems to Improve the Treatment of Keratitis
POLAT H. K., Kurt N., AYTEKİN E., Pehlivan S. B., ÇALIŞ S.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
, cilt.38, sa.6, ss.376-395, 2022 (SCI-Expanded, Scopus)
2020
20208. Design of ocular drug delivery platforms and in vitro - in vivo evaluation of riboflavin to the cornea by non-interventional (epi-on) technique for keratoconus treatment
AYTEKİN E., ÖZTÜRK N., Vurla İ., POLAT H. K., Cakmak H. B., ÇALIŞ S., et al.
Journal of Controlled Release
, cilt.324, ss.238-249, 2020 (SCI-Expanded, Scopus)
2020
20209. Development of besifloxacin HCl loaded nanofibrous ocular inserts for the treatment of bacterial keratitis: In vitro, ex vivo and in vivo evaluation
POLAT H. K., Pehlivan S. B., Ozkul C., ÇALAMAK S., Ozturk N., AYTEKİN E., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.585, 2020 (SCI-Expanded, Scopus)